IP Library Granted Patent US 7,381,533
Granted Patent B2
US 7,381,533 · App. 11/295,993 · Granted Jun 3, 2008

Electrodes linked via oligomers to nucleic acids

Assignee: Clinical Micro Sensors, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,381,533
App. No.
11/295,993
Granted
Jun 3, 2008
Kind
B2
Abstract

The invention relates to nucleic acids covalently coupled to electrodes via conductive oligomers. More particularly, the invention is directed to the site-selective modification of nucleic acids with electron transfer moieties and electrodes to produce a new class of biomaterials, and to methods of making and using them.

Claims (16)

1. A composition comprising:

a) an electrode comprising:

i) a monolayer; and

ii) a first nucleic acid covalently attached to said electrode via a spacer; and

b) a second nucleic acid comprising at least one electron transfer moiety (ETM) covalently attached to said second nucleic acid.

2. A composition according to claim 1 wherein said spacer is a conductive oligomer.

3. A compositions according to claim 1 wherein said spacer is an insulator.

4. A composition according to claim 1 wherein said spacer comprises alkyl chains.

5. A composition according to claim 1 wherein said second nucleic acid comprises a plurality of ETMs.

6. A composition according to claim 1 wherein said ETM is a metallocene.

7. A composition according to claim 6 wherein said metallocene is ferrocene.

8. A composition according to claim 7 wherein said ferrocene is a ferrocene derivative.

9. A composition according to claim 1 wherein said monolayer comprises conductive oligomers.

10. A composition according to claim 1 wherein said monolayer comprises insulators.

11. A composition according to claim 1 further comprising a target sequence, wherein said target sequence, said first nucleic acid, and said second nucleic acid form a hybridization complex.

12. A composition according to claim 11 wherein said target sequence comprises a first domain and a second domain, wherein said first nucleic acid hybridizes to said first domain and said second nucleic acid hybridizes to said second domain.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2021
From: GENMARK DIAGNOSTICS, INC.
To: ROCHE MOLECULAR SYSTEMS, INC.
Reel/Frame 058189/0563 →
RELEASE OF SECURITY INTEREST Recorded Oct 9, 2012
From: SQUARE 1 BANK
To: OSMETECH TECHNOLOGY, INC.
Reel/Frame 029097/0148 →
SECURITY INTEREST Recorded Apr 1, 2010
From: OSMETECH TECHNOLOGY INC.
To: SQUARE 1 BANK
Reel/Frame 024312/0662 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2008
From: CLINICAL MICRO SENSORS INC. (DBA OSMETECH MOLECULAR DIAGNOSTICS)
To: OSMETECH TECHNOLOGY INC.
Reel/Frame 021924/0376 →
Continuity (3)
Continuation 0887397800 · Jun 12, 1997
Continuation In Part 0874379800 · Nov 5, 1996
Related Publication 20060099631A1 · May 11, 2006